--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business ...

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

When Julie Kim ’97 MBA graduated from the Kellogg School of Management ... You can sense this in other Kellogg graduates when you meet them out in the world.” President of Takeda Pharmaceutical ...

Global pharmaceutical giant Takeda Group has appointed Julie Kim, the current head of its U.S. subsidiary, as the next chief executive officer (CEO) of the group. Takeda is the largest corporation ...

Julie Kim, president of the company's U.S. unit, was named to succeed Weber in June 2026. Weber, one of the highest-profile foreign CEOs in Japan, spearheaded Takeda's $59 billion takeover of ...

Does Warren Buffett Know Something Wall Street Doesn't? He's Done This 1 Thing for the First Time in 30 Years, and It May Be a Warning for Investors. Satya Nadella Said 'We Should Take Development ...

The appointment of Julie Kim, who has extensive experience and familiarity with Takeda’s operations, is expected to be favorably received. Furthermore, the company’s pipeline remains robust ...

We apologize, but this video has failed to load. “The Board of Directors has unanimously chosen Julie Kim to lead Takeda into the next chapter, building on the company’s success under Christophe Weber ...